Robin J. Ziegler - Concepedia

Concepedia

Author

Robin J. Ziegler

Icahn School of Medicine at Mount Sinai

Also Known As

R. Ziegler, R.J. Ziegler, Robin J Ziegler, Robin J. Ziegler, Robin Ziegler

39

Publications

2.2K

Citations

23

H-Index

84

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai SynZyme Technologies (United States)University of Cambridge Sanofi (United States)Vrije Universiteit Amsterdam

RJ

About

Robin J. Ziegler is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	691
2	Natural Sciences	3	3	183
3	Social Sciences	3	3	149
4	Health Sciences	2	2	54
5	Allergy	1	1	49

Robin J. Ziegler

×

28

Publications

2.2K

Citations

23

H-Index

	Year	Citations
Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the Lung Edward R. Lee, John Marshall, Craig Siegel, Human Gene Therapy	1996	443
Glycoengineered Acid α-Glucosidase With Improved Efficacy at Correcting the Metabolic Aberrations and Motor Function Deficits in a Mouse Model of Pompe Disease Yunxiang Zhu, Ji-Lei Jiang, Nathan Gumlaw, Molecular Therapy	2009	168
Effective gene therapy in an authentic model of Tay-Sachs-related diseases María Begoña Cachón-González, Susan Z. Wang, Robin J. Ziegler, Proceedings of the National Academy of Sciences	2006	147
AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice Robin J. Ziegler, Scott Lonning, Donna Armentano, Molecular Therapy	2003	135
Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy Gregory D Hurlbut, Robin J. Ziegler, Jennifer B. Nietupski, Molecular Therapy ImmunologyPathologyImmunotherapyLiver TransductionCell Transplantation	2010	134
High and Sustained Transgene Expression in Vivo from Plasmid Vectors Containing a Hybrid Ubiquitin Promoter Nelson S. Yew, Malgorzata Przybylska, Robin J. Ziegler, Molecular Therapy	2001	133
Optimization of Plasmid Vectors for High-Level Expression in Lung Epithelial Cells Nelson S. Yew, Donna M. Wysokenski, Kathryn X. Wang, Human Gene Therapy ImmunologyMolecular BiologyHigh-level ExpressionCellular PhysiologyBovine Growth Hormone	1997	117
Correction of the Biochemical and Functional Deficits in Fabry Mice Following AAV8–mediated Hepatic Expression of α-galactosidase A Robin J. Ziegler, Maribeth Cherry, Christine M. Barbon, Molecular Therapy	2006	87
Gene Transfer Corrects Acute GM2 Gangliosidosis—Potential Therapeutic Contribution of Perivascular Enzyme Flow María Begoña Cachón-González, Susan Z. Wang, Rosamund McNair, Molecular Therapy	2012	76
Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse Marco A. Passini, Jie Bu, Jonathan A. Fidler, Proceedings of the National Academy of Sciences ImmunologySystemic InjectionsSocial SciencesNiemann-pick MouseNeuroinflammation	2007	67

Page 1